Interleukin-2 (IL-2) gene therapy with allogeneic fibroblasts in the CT-26 model of murine colorectal carcinoma

Oncology Reports

Volumn 4, Issue 1, 1997, Pages 135-138

  Shawler, Daniel L ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

Colon cancer; Gene therapy; Immunotherapy; Interleukin 2

Indexed keywords

INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FIBROBLAST; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031017717     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.1.135     Document Type: Article

References (2)

1. Fearon ER, Pardoll DM, Itaya T, et al: Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60: 397-403, 1990.
2. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R and Gilboa E: Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172: 1217-1224, 1990.